experspadmin

Tardive Dyskinesia, Drug-Induced Parkinsonism, and the Role of Anticholinergic Medications
Psychiatry

Tardive Dyskinesia, Drug-Induced Parkinsonism, and the Role of Anticholinergic Medications

clinical topic updates
By Leslie Citrome, MD, MPH
Emerging Immuno-Myeloid Therapies in MDS and AML
Uncategorized

Emerging Immuno-Myeloid Therapies in MDS and AML

expert roundtables
By Andrew M. Brunner, MD; Courtney D. DiNardo, MD, MSCE; Rami S. Komrokji, MD
Improving Response Durability in High-Risk MDS and AML
Uncategorized

Improving Response Durability in High-Risk MDS and AML

expert roundtables
By Andrew M. Brunner, MD; Courtney D. DiNardo, MD, MSCE; Rami S. Komrokji, MD
Integrating Genomics Into the Classification and Management of MDS
Uncategorized

Integrating Genomics Into the Classification and Management of MDS

expert roundtables
By Andrew M. Brunner, MD; Courtney D. DiNardo, MD, MSCE; Rami S. Komrokji, MD
Promising Lower-Intensity Regimens for Patients With High-Risk MDS and AML
Uncategorized

Promising Lower-Intensity Regimens for Patients With High-Risk MDS and AML

expert roundtables
By Andrew M. Brunner, MD; Courtney D. DiNardo, MD, MSCE; Rami S. Komrokji, MD
Load More